The National Heart, Lung, and Blood Institute (NHLBI) awarded a $767,805 Delivery Order contract to The Leland Stanford Junior University (Stanford University) for a "Biorepository of Human Induced Pluripotent Stem Cells for Cardiovascular Diseases (BHIPSC-CVD) - Task A. Core Study Operations." This contract, which does not have a set-aside designation, supports medical research and the development of a biorepository of stem cells for cardiovascular disease studies. Stanford...
This federal contract award to Stemcell Technologies Inc., a foreign-owned biotechnology company, is for the provision of STEMCELL REAGENTS FOR TRANSPLANT SERVICES to the Defense Health Agency. The $73,872.44 firm fixed-price purchase order has an ultimate completion date of April 3, 2025. Stemcell Technologies Inc. is the prime contractor, and the contract was not set aside for small businesses. The contract award indicates that Stemcell Technologies Inc. has an established presence in...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company, to provide specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research initiatives across various government agencies. The contract, valued at...
This is a federal contract award to Wicell Research Institute, Inc., a non-profit organization, by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services. The contract, valued at $16,137,048.00, is for the provision of human pluripotent stem cell lines, testing, and related services to support biomedical research. Wicell is a global leader in stem cell banking and distribution, and has provided specific cell lines to the National Institutes...
This federal contract award is for STEMCELL Technologies Inc. to provide reagents and consumables for the RoboSep-S Cell Separator Systems used at the National Institutes of Health (NIH) Clinical Center. The award, valued at $39,232.00, is a Firm Fixed Price Purchase Order issued on a sole source basis, as STEMCELL Technologies Inc. is the only known vendor capable of supplying the proprietary supplies required for the existing RoboSep-S instruments at the NIH Clinical Center. The contract...
This federal contract award, valued at $54,102.50, was issued by the National Institute of Environmental Health Sciences (NIEHS) to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. presence in Kent, Washington. The contract is for the acquisition of a RoboSep-S automated cell separator, which uses EasySep immunomagnetic cell separation technology to enable positive and negative selection of desired cells from various sample sources. This...
This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $11,593.80 award is for the delivery of HU PB MONOCYTES, CRYO, 4X10E7 (2 VIALS), with a completion date of July 15, 2024. The contract has no set-aside designation. Stemcell Technologies Inc. is a supplier of...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to Southwest Research Institute, a non-profit organization, under Broad Agency Announcement PMQWP#186 to "EVALUATE THE SAFETY AND QUALITY OF A 3D PRINTED, SINGLE-USE BIOREACTOR FOR BEADS-FREE CART T-CELL MANUFACTURING". The $2,455,483.29 cost-plus-fixed-fee contract has a completion date of September 30, 2023 and does not have a set-aside designation. Southwest Research...
This $1,999,706 firm-fixed-price definitive contract was awarded by NASA's Ames Research Center to The Leland Stanford Junior University, a private non-profit research institution, to assess the long-term effects of radiation exposure on engineered heart and vascular tissues. The contract is not set-aside. The award is related to a multi-agency NASA Research Announcement seeking proposals to develop 3D tissues and microphysiological systems with at least 6 months of extended longevity to model...
This is a cost-reimbursable delivery order contract awarded by the National Heart Lung and Blood Institute, a component of the National Institutes of Health, to the Leland Stanford Junior University (Stanford University) for the BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLS FOR CARDIOVASCULAR DISEASES (BHIPSC-CVD) - TASK AREA B. The $4,161,434.00 contract has an ultimate completion date of April 25, 2025 and does not utilize a set-aside designation, indicating Stanford competed for the...